Galmed Pharmaceuticals (EOCN) Invested Capital (2013 - 2026)
Galmed Pharmaceuticals (EOCN) recorded Invested Capital of $13.57 million in Q2 2026, down 37.1% from $21.58 million a year earlier and down 5.1% from the prior quarter.
Galmed Pharmaceuticals (EOCN) Invested Capital (2013 - 2026) Analysis & Trends
For FY2025, Galmed Pharmaceuticals reported Invested Capital of $16.62 million, down 1.0% from FY2024.
- Annual Invested Capital has a five-year compound annual growth rate of -18.1% (FY2020 to FY2025).
- Across earlier years, Invested Capital came in at $16.79 million in FY2024 (+13.8%), $14.75 million in FY2023 (+5.7%), $13.96 million in FY2022 and -$29.49 million in FY2021.
- The Q2 2026 figure is the lowest quarterly Invested Capital since Q2 2024.
- On a year-over-year basis, Invested Capital has declined for three consecutive quarters, with growth averaging 11.4% over the last eight quarters.
- Peak year-over-year performance for Invested Capital in the last five years was growth of 77.7% in Q2 2025, against a decline of 58.7% in Q3 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $14.3 million (Q1 2026), $16.62 million (Q4 2025) and $19.91 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 134.01 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 64.89 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 95.89 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 79.44 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 50.26 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 68.99 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 38.08 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 148.69 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Galmed Pharmaceuticals | 406,071.97 | 406,071.97 | - | 13.57 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.57 Mn |
| Mar 31, 2026 | 14.30 Mn |
| Dec 31, 2025 | 16.62 Mn |
| Sep 30, 2025 | 19.91 Mn |
| Jun 30, 2025 | 21.58 Mn |
| Mar 31, 2025 | 17.38 Mn |
| Dec 31, 2024 | 16.79 Mn |
| Sep 30, 2024 | 19.61 Mn |
| Jun 30, 2024 | 12.14 Mn |
| Mar 31, 2024 | 13.14 Mn |
| Dec 31, 2023 | 14.75 Mn |
| Sep 30, 2023 | 16.07 Mn |
| Jun 30, 2023 | 11.14 Mn |
| Mar 31, 2023 | 12.53 Mn |
| Dec 31, 2022 | 13.96 Mn |
| Sep 30, 2022 | 16.03 Mn |
| Jun 30, 2022 | 21.35 Mn |
| Mar 31, 2022 | 25.18 Mn |
| Dec 31, 2021 | -29.49 Mn |
| Sep 30, 2021 | 38.79 Mn |
Galmed Pharmaceuticals Invested Capital API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=invested-capital&ticker=EOCN&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "invested-capital", "ticker": "EOCN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=invested-capital&ticker=EOCN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();